HIFU Resource Center Online at www.urotoday.com EDAP and the Ablatherm-HIFU now have a HIFU section in the most popular urology web site in the world : http://www.urotoday.com . Urotoday.com is a scientific web site serving urologists visited by more than 50,000 urologists every month worldwide.
EDAP Revises Termination Agreement With HealthTronics LYON, France , July 16 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports today an update to its Termination Agreement with HealthTronics,
EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer LYON, France , Aug. 17 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, is
EDAP TMS S.A. to Release 2007 Second Quarter Results LYON, France , Aug. 16 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and
Recent US News & World Report Feature Highlights HIFU as Future of Prostate Cancer Therapy A recent article found in US News & World Report highlights HIFU and robotic surgery as key treatments of the future in the fight against early stage prostate cancer.
European Growth Continues, HIFU Division Returns to Profitability Retains Experienced North American Prostate Cancer Leader to Drive USA Programs Lyon, France, August 30, 2007 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer
Vanderbilt-Ingram Cancer Center recently issued the following press release announcing its participation in the US Clinical Trial Study of the Ablatherm-HIFU device from EDAP.
EDAP Launches Enhanced Communication Plans at SIU Paris Congress LYON, France , Sept. 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and a major global provider of stone breaking products,